Holen Sie sich die Stockscreener-App
20.78
2.76%
-0.59
Handel nachbörslich:
20.78
Finanzdaten der Viridian Therapeutics Inc-Aktie (VRDN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
4.17%
0.075
|
0.072 | 0.086 | 0.072 | 0.072 |
| Operating Expenses |
13.74%
106.84
|
93.94 | 83.57 | 72.26 | 55.97 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
13.74%
106.84
|
93.94 | 83.57 | 72.26 | 55.97 |
| Operating Income/Loss |
13.74%
-106.77
|
-93.87 | -83.48 | -72.19 | -55.90 |
| Nonoperating Income/Loss |
13.26%
6.032
|
6.954 | 6.791 | 7.194 | 7.355 |
| Income/Loss From Continuing Operations Before Tax |
100.09%
0.075
|
-86.91 | 0.086 | -64.99 | -48.54 |
| Income/Loss From Continuing Operations After Tax |
15.90%
-100.73
|
-86.91 | -76.69 | -64.99 | -48.54 |
Net Income/Loss
|
15.90%
-100.73
|
-86.91 | -76.69 | -64.99 | -48.54 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):